As many of you know, NYU Langone Medical Center was hit hard by Hurricane Sandy last October, forcing us to close our inpatient hospital for many weeks. We were able to continue providing outpatient cancer services at the NYU Clinical Cancer Center, and our staff rallied to provide the very best care that our patients have come to expect. The reopening of our hospital in January was a remarkable achievement, and today we are stronger than ever. Thus we began this year feeling revitalized and reenergized, and I felt more grateful than ever for such a dedicated cadre of staff members who pull together in times of crisis so we can continue to meet our mission.
We were also delighted last year to earn the renewal of our federal support as a National Cancer Institute (NCI)-designated cancer center. We continued to build our ranks of physicians, scientists, and faculty who do both. And we held our Annual Gala on October 17 at The Plaza, where our generous supporters gathered to celebrate the progress we’ve made and our plans for the future.
In this issue, you’ll be able to read about progress we are making to understand the fundamental causes of cancer — in this case, how chronic inﬂammation and bacteria may instigate cancer development and growth. This is truly a multidisciplinary effort involving collaborations among laboratory researchers, clinicians, and population science investigators. This line of inquiry is a perfect example of the strides that can be made at a cancer center like ours, which is afﬁliated with a larger university family.
Speaking of family, another article in this issue offers guidance on how to respond when a loved one tells you he or she has cancer. We talk about how important it is to offer positive support while letting your loved ones call the shots about what they need and are ready to receive from you.
Another way to help patients through the journey of cancer is to offer integrative medicine services. I’d like to thank Bonnie Pfeifer Evans for her generous contribution to support integrative oncology programs that may beneﬁt women with breast cancer. Programs such as these demonstrate the commitment of the NYUCI to treating the whole person, not just the disease.
Finally, I’d like to take this opportunity to welcome several new faculty members and board members to our team, whom you can read about in this issue. Of course, you are vital members of our team as well. I’d like to thank you for your support and your continued faith in the mission of the NYU Cancer Institute.
William L. Carroll, MD
The Julie and Edward J. Minskoff Professor of Pediatrics
Professor of Pathology
Director, NYU Cancer Institute